Preclinical data in DIPG has demonstrated that concomitant treatment with WEE1 kinase inhibitor, AZD-1775, impairs radiation-induced G2/M cell cycle checkpoint and enhances radiation-induced cell death in pediatric glioma cell lines. Here, WEE1 is linked to diffuse intrinsic pontine glioma.